Lysophosphatidic acid produced by Autotaxin acts as an allosteric modulator of its catalytic efficiency
F. Salgado-Polo, A. Fish, M.-T. Matsoukas, T. Heidebrecht, W.-J. Keune, A. Perrakis
Abstract
Autotaxin is a secreted phosphodiesterase that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). LPA controls key cellular responses such as migration, proliferation and survival, implicating ATX-LPA signalling in various (patho)physiological processes and establishing it as a drug target. ATX structural and functional studies have revealed an orthosteric and an allosteric site, the \"pocket\" and the \"tunnel\". Here, we revisit the kinetics of the ATX catalytic cycle in light of allosteric regulation, dissecting the different steps and pathways that lead to LPC hydrolysis. Consolidating all experimental kinetics data to a comprehensive catalytic model supported by molecular modelling simulations, suggests a positive feedback mechanism, regulated by the abundance of the LPA products activating hydrolysis of different LPC species. Our results complement and extend current understanding of ATX hydrolysis in light of the allosteric regulation by produced LPA species, and have implications for the design and application of orthosteric and allosteric ATX inhibitors.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Autotaxin facilitates selective LPA receptor signaling
F. Salgado-Polo, R. Borza, … A. Perrakis·bioRxiv·Apr 9, 2022
- Linking medicinal cannabis to autotaxin-lysophosphatic acid signalling.
M. C. Eymery, A. A. McCarthy, J. Hausmann·bioRxiv·Jul 1, 2022
- Lysophosphatidic acid controls autotaxin binding to 1-integrin: impact on disease progression in murine collagen-induced arthritis.
Mathias Emery, Cinthia N. Cuero, … Olivier Peyruchaud·bioRxiv·Apr 4, 2025
- A type IV Autotaxin inhibitor ameliorates acute liver injury and non-alcoholic steatohepatitis in mice
Richell S. Booijink, Fernando Salgado-Polo, … Ruchi Bansal·bioRxiv·May 19, 2022
- Structural basis for ATP regulation of human 5-lipoxygenase
Tarvi Teder, Federico Pozzani, … Jesper Z. Haeggström·bioRxiv·Nov 26, 2025
- Two distinct mechanisms of small molecule inhibition of LpxA acyltransferase essential for lipopolysaccharide biosynthesis